Opportunity
Simpler Grants.gov #PA-25-169
NIH Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
Buyer
National Institutes of Health
Posted
January 08, 2025
Respond By
May 07, 2026
Identifier
PA-25-169
NAICS
541715
The National Institutes of Health (NIH) is seeking research proposals for the Trailblazer Award, specifically for New and Early Stage Investigators. - Government Buyer: - National Institutes of Health (NIH) - Purpose and Scope: - Supports research integrating engineering and physical sciences with life and biomedical sciences - Focus on exploratory, developmental, proof of concept, or high risk-high impact projects - Eligibility and Requirements: - Open to a wide range of educational, business, government, nonprofit, and other organizations (excluding non-domestic entities) - No preliminary data required; minimal data allowed if clearly marked and limited to one-half page with one figure - No cost sharing or matching required - Funding Details: - Grant funding instrument - No specific products or services requested; applicants must propose research programs - Notable Aspects: - Opportunity is for research grants, not procurement of goods or services - Administered under Assistance Listings 93.286, 93.867, and 93.866 - Designed to encourage innovative, high-impact research from new investigators
Description
This Trailblazer Award is an opportunity for NIH-defined New and Early Stage Investigators to pursue research programs integrating engineering and physical sciences with life and biomedical sciences. Projects may be exploratory, developmental, proof of concept, or high risk-high impact, and can be technology design-directed, discovery-driven, or hypothesis-driven. No preliminary data are required, expected, or encouraged, but minimal preliminary data are allowed and must be clearly marked and limited to one-half page with one figure. The award supports research approaches with minimal or no preliminary data.